The case / progressive hypertension and proteinuria on anti-angiogenic therapy.
Obhrai
Jagdeep S
JS
Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. jobhrai@rics.bwh.harvard.edu
Patel
Tejas V
TV
Humphreys
Benjamin D
BD
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D007211:Indoles / Q000009:adverse effects; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D008954:Models, Biological; D011507:Proteinuria / Q000209:etiology*; D011758:Pyrroles / Q000009:adverse effects; D000077210:Sunitinib; D013577:Syndrome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000077210:Sunitinib